Spiriva Respimat (tiotropium bromide)

pCPA File Number: 20869

Negotiation Status:

Concluded with an LOI

Indication(s):

Chronic Obstructive Pulmonary Disease (COPD)

Sponsor/Manufacturer:

Boehringer Ingelheim (Canada) Ltd.

CDA-AMC Project Number:

SR0412-000

pCPA Engagement Letter Issued:

2015-08-21

Negotiation Process Concluded:

2016-03-02